- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03978533
Low Intensity Family Support for Refugees in an LMIC
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
RATIONALE The rapidly growing scale of global humanitarian crises requires new response capabilities geared towards addressing populations with prolonged high vulnerability to mental health consequences and little access to health and social resources. The World Health Organization (WHO), under the leadership of Dr. Mark van Ommeren, has been advocating for low resource-intensity cognitive behavioral therapy (LICBT) for such conditions. They conducted two large RCTs of Problem Management Plus (PM+), a brief, basic, one-on-one, paraprofessional-delivered version of LICBT for adults, which demonstrated clinically significant reductions in anxiety and depressive symptoms at 3 months. LICBT could help to address some needs among Syrian refugees, but our recent D43 supported longitudinal study of 30 Syrian refugee families in Istanbul, found that one key challenge is its fit with the strong family context of Syrians. The investigators found evidence of families with adult and/or children with CMD symptoms and challenges managing stress, but also evidence of family strengths and resilience, and families facing multiple adverse challenges. In August 2017, Dr. Weine met with Dr. van Ommeren at the WHO, and they agreed to work in partnership to extend the WHO's LICBT approach to families. In September 2017, Weine et al convened a roundtable with key stakeholders in Istanbul, which reached a consensus about the need for a new family intervention that included elements of PM+ but also of family interventions, for delivery in a group format. Specifically, the investigators chose to incorporate elements of Coffee and Families Education and Support (CAFES), a NIMH funded family support and education intervention that the investigators previously developed and evaluated with refugee families from Bosnia and Kosovo. Other key implementation challenges are who will conduct the intervention, what training do they require, what organizational capacity is required, and how to best integrate FS into community and clinical sites.
AIM 1 To form a Family Support Design Team (FSDT) to adopt the PM+ and CAFES manuals into a family support (FS) intervention for use with Syrian refugee families by lay providers in community sites and nurses in clinical sites using a four-session multiple family group format.
AIM 2 To pilot FS with families in community and clinical sites, and then through observations and qualitative interviews, to assess FS's feasibility, fidelity, the impact of context and local capacity, the experiences of intervention delivery, and practitioner and organizational perspectives on scale up.
AIM 3 To conduct pre, immediate post, and 3-month post assessments of the Syrian refugee families who received FS through all the sites, to demonstrate the kind of pre-post changes that have been reported for comparable interventions and to determine key parameters of interest with sufficient accuracy and precision.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Istanbul, Turkey
- Can Association
-
Istanbul, Turkey
- Hiraeth
-
Istanbul, Turkey
- Insan for Psychosocial Support
-
Istanbul, Turkey
- Syrian Nour Association
-
Istanbul, Turkey
- Turkish Red Crescent
-
Istanbul, Turkey
- Yusra Community Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Syrian refugee family living in Istanbul
- contains both adult caregivers (18-55) and at least one of their children (<18 and >11 years) living in one household
- one adult or adolescent with > 3 on the GHQ-12
- willing to participate in the intervention and research procedures
- able to give written informed consent
Exclusion Criteria:
• Families who do no have a child <18 and >11 years old
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Family Support Group
Family Support Groups will be piloted with families in community and clinical sites.
Each pair of facilitators will pilot two groups of 6 families each.
Each group is 4 sessions lasting 2 hours each.
Each of the sessions incorporates didactic talks, family discussion, and separate breakout groups for adolescents and adults.
Family Support intervention incorporates cognitive-behavioral theory of PM+ which underlies evidence-based techniques focused on stress management and behavioral activation.
Family support intervention also incorporates resilience theory, which explains family protective processes that can ameliorate the negative consequences of hardships and challenges and enable healing and growth in families.
|
Family Support Groups will be piloted with families in community and clinical sites.
Each pair of facilitators will pilot two groups of 6 families each.
Each group is 4 sessions lasting 2 hours each.
Each of the sessions incorporates didactic talks, family discussion, and separate breakout groups for adolescents and adults.
Family Support intervention incorporates cognitive-behavioral theory of PM+ which underlies evidence-based techniques focused on stress management and behavioral activation.
Family support intervention also incorporates resilience theory, which explains family protective processes that can ameliorate the negative consequences of hardships and challenges and enable healing and growth in families.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline of Strengths and Difficulties Questionnaire at immediate post and three months post intervention
Time Frame: baseline, immediate post, three months post
|
Strengths and Difficulties Questionnaire (SDQ) is a brief behavioural screening questionnaire about 3-16 year olds. For this project, the adolescent version will be used for ages 11-17. The questionnaire comprises 5 scales of 5 items each. Total difficulties score: This is generated by summing scores from all the scales except the prosocial scale. Scoring is close to average; slightly raised (/slightly lowered); high (/low); very high (very low) Total difficulties score: 0-14; 15-17; 18-19; 20-40 Emotional problems score: 0-4; 5; 6; 7-10 Conduct problems score: 0-3; 4; 5; 6-10 Hyperactivity score: 0-5; 6; 7; 8-10 Peer problems score: 0-2; 3; 4; 5-10 Prosocial score:7-10; 6; 5; 0-4 |
baseline, immediate post, three months post
|
|
Change from baseline of Kansas Parental Satisfaction Scale at immediate post and three months post intervention
Time Frame: baseline, immediate post, three months post
|
Kansas Parental Satisfaction Scale (KPSS) asks three questions about their satisfaction with a) their children's behavior, b) them as a parent, and c) their relationship with their children.
The instrument uses a 7-point Likert scale with response choices ranging from 1 ("extremely dissatisfied") to 7 ("extremely satisfied").
The scores for all three items are summed to yield a total parenting satisfaction score.
Scores range from 3 - 21. Scores of 15 or less indicate low parental satisfaction.
|
baseline, immediate post, three months post
|
|
Change from baseline of PTSD Checklist for DSM-5 at immediate post and three months post intervention
Time Frame: baseline, immediate post, three months post
|
PTSD Checklist for DSM-5 (PCL-5) is a 20-item self-report measure that assesses the 20 DSM-5 symptoms of PTSD.
The PCL-5 has a variety of purposes, including: Monitoring symptom change during and after treatment; Screening individuals for PTSD; Making a provisional PTSD diagnosis.
The PCL-5 is a self-report measure that can be completed by patients in a waiting room prior to a session or by participants as part of a research study.
It takes approximately 5-10 minutes to complete.The self-report rating scale is 0-4 for each symptom.
Rating scale descriptors are the same: "Not at all," "A little bit," Moderately," "Quite a bit," and "Extremely."
Treating each item rated as 2 = "Moderately" or higher as a symptom endorsed, then following the DSM-5 diagnostic rule which requires at least: 1 Criterion B item (questions 1-5), 1 Criterion C item (questions 6-7), 2 Criterion D items (questions 8-14), 2 Criterion E items (questions 15-20).
|
baseline, immediate post, three months post
|
|
Change from baseline Hospital Anxiety Depression Scale at immediate post and three months post intervention
Time Frame: baseline, immediate post, three months post
|
HADS (Hospital Anxiety and Depression Scale) aims to measure symptoms of anxiety (HADS Anxiety) and depression (HADS Depression).The HADS is a fourteen item scale; seven of the items relate to anxiety and seven relate to depression.
Each question is scored 0-3, a person can score between 0 and 21 for either anxiety or depression.
For both scales of depression or anxiety, a score of 0-7 is normal, 8-10 is mild, 11-14 is moderate, and 15-21 is severe.
|
baseline, immediate post, three months post
|
|
Change from baseline General Health Questionnaire at immediate post and three month post intervention
Time Frame: baseline, immediate post, three months post
|
General Health Questionnaire (GHQ-12) is a screening device for identifying minor psychiatric disorders in the general population.
The GHQ-12 is a quick, reliable and sensitive short form that is ideal for research studies.
The GHQ-12 yields an overall total score.
The GHQ scoring is 0-0-1-1, with a score range from 0-12.
Any score exceeding the threshold value of 3 as achieving 'caseness'.
|
baseline, immediate post, three months post
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change from baseline Family Communication Questionnaire at immediate post and three month post intervention
Time Frame: baseline, immediate post, three months post
|
Family Communication Questionnaire is a measure that assess how often and how comfortable the family is about communicating on certain issues.
There are six items, each with a question on how often they talk about an issue (responses include: a lot, often, once in a while, we don't talk about this) and a question on how comfortable they are talking about the issue asked (responses include: very comfortable, somewhat comfortable, somewhat uncomfortable, very very uncomfortable) for a total of 12 items that are scored 0-3, for a total score of 36.
High scores indicate low family communication, with cut of score of 24 and above for low family communication.
|
baseline, immediate post, three months post
|
|
Change in baseline Knowledge and Attitudes Regarding Trauma Mental Health Questionnaire at immediate post and three month post intervention
Time Frame: baseline, immediate post, three months post
|
This construct is assessed using a 28 item questionnaire. There are two sub-scales that assess knowledge and attitude. The knowledge sub-scale (13 items) presents items with varying level of difficulty to address the degree to which the subject is informed about the conditions and treatment of PTSD and Depression, and cost, availability, and accessibility of services. Items are scored for "true," "false," or "can't say". There is no total score, rather assessing their change in knowledge over time. The attitude sub-scale (15 items) assesses the degree to which subjects consider the trauma related mental health problems to be addressable. Items are scored on a 4-point scale from 0-4 for "strongly agree" to "strongly disagree" for a total score of 60. Some items are reverse scored, a score of 30 or higher indicates positive attitudes and below 30 indicates negative attitude. |
baseline, immediate post, three months post
|
Collaborators and Investigators
Investigators
- Principal Investigator: Stevan Weine, MD, University of Illinois at Chicago
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2018-0547
- R21MH117759 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of MinnesotaCompletedDepression SymptomsUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
Clinical Trials on Family Support Group
-
Kastamonu UniversityCompletedAnxiety | Patient Satisfaction | Patient ComfortTurkey
-
Mental Health Services in the Capital Region, DenmarkMental Health Centre North ZealandUnknown
-
Chi-Wen ChenNot yet recruitingHeart Defects, CongenitalTaiwan
-
University of OregonCompletedThe Positive Family Support Project - Partnering With Families for a Successful Transition to SchoolAchievementUnited States
-
Children's Hospital of PhiladelphiaAgency for Healthcare Research and Quality (AHRQ)Completed
-
University of PittsburghNational Institute on Aging (NIA)CompletedPhysician-Family Communication in Intensive Care Units | Surrogate Decision-making for Critically Ill PatientsUnited States
-
Rahel NaefSwiss National Science FoundationCompletedQuality of Life | Posttraumatic Stress Disorder | Depression, Anxiety | Postintensive Care Syndrome | Family Members | Family DynamicsSwitzerland
-
Rigshospitalet, DenmarkCompletedNeoplasms | Lymphoma | Hematologic Diseases | Leukemia, Myeloid | Multiple Myeloma | Bone Marrow TransplantationDenmark
-
Children's Mercy Hospital Kansas CityCompleted
-
University of PittsburghDuke University; National Institute on Aging (NIA); Oregon Health and Science... and other collaboratorsCompleted